NDC 62175-272
Oxybutynin ChlorideExtended Release 15 mg tablet, extended release
On the label: Lannett Company, Inc..
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Lannett Company, Inc. names for other drugs.
Recalls
- Feb 21, 2019 · Class III · Lannett Company Inc.
Failed Dissolution Specifications
Lots: Lots: 18226783A, exp 07/2021 and 18232540A, exp 08/2021
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Oxybutynin: every company that makes it
- Form
- tablet, extended release, oral
- Strength
- 15 mg
- Approval
- ANDA ANDA078503
- On the market since
- Mar 1, 2009
- Package NDCs
62175-272-3762175-272-41- Official label
- DailyMed (National Library of Medicine), updated May 30, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?